In this article, we reviewed Fisher Asset Management's stock portfolio strategy and examined billionaire Ken Fisher's top 10 high dividend stock picks that have a dividend yield...
Keep Reading →
April 2 - Hedge Funds, News
Below are billionaire Ken Fisher's top 5 high dividend stock picks.
Keep Reading →
April 2 - Hedge Funds, News
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus talks, many smart money investors ...
Keep Reading →
December 21 - Hedge Funds, News
Below we present the list of 5 Best Dividend Stocks To Buy According To Billionaire Ken Fisher.
Keep Reading →
November 14 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
September 27 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
July 12 - Hedge Funds, News
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
June 9 - Hedge Funds, News
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (...
Keep Reading →
May 31 - Stock Analysis
Michael Castor predicted the coronavirus pandemic when most investors were dismissing the threat.
Keep Reading →
April 30 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
March 12 - Hedge Funds, News
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Keep Reading →
January 9 - Hedge Funds, News
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Keep Reading →
December 5 - ETF Trading, Hedge Funds, News
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018 as investors first worried over the possible...
Keep Reading →
October 9 - Hedge Funds, News
Is GlaxoSmithKline plc (NYSE:GSK) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Keep Reading →
June 14 - Hedge Funds, News
Billionaire hedge fund managers such as David Abrams, Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential...
Keep Reading →
March 27 - Hedge Funds, News
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could...
Keep Reading →
December 11 - Hedge Funds, News
Fisher Investments was founded in 1979 by billionaire Ken Fisher.
Keep Reading →
November 13 - Dividend Stocks, Hedge Funds, News
NEW YORK (Reuters) - Hedge fund manager Jim Chanos says he is betting that the stocks of physican practice management companies Mednax (MD.N) and Envision Healthcare (EVHC.N) ...
Keep Reading →
July 18 - Hedge Funds, Insider Trading
The 10 biggest antidepressant drug companies in 2017 are committed to providing the safest and most cost-effective solution for consumers suffering from mental diseases worldwide...
Keep Reading →
December 14 - Lists, News
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Keep Reading →
November 24 - News
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Keep Reading →
November 23 - News
If you're looking to lose weight, we've compiled a list of 7 medically proven weight loss supplements that work. As summer is already here, if you slacked off throughout the...
Keep Reading →
June 17 - News
"U.S. stocks edged lower on Tuesday as weakness in the energy and financial sectors outweighed gains in technology shares.
Keep Reading →
May 30 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of...
Keep Reading →
April 15 - Hedge Funds
Before we get to the list of 7 over-the-counter diet pills that work without exercise, we should ask ourselves if there exists such a thing. The short answer is no.
Keep Reading →
April 12 - Lists, News
The 10 least obese countries in the world are mostly from Asia and Africa.
Keep Reading →
March 26 - Lists, News
Are you interested in knowing the 7 Most Popular Diet Pills That Work Fast Without Exercise? I mean what better way to lose weight than to simply pop some pills and let the fat...
Keep Reading →
March 15 - Lists, News
Most HIV patients have no options in regard to how they must consume their medication.
Keep Reading →
February 14 - News, Stock Analysis
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has announced the approval of AirDuo RespiClick and ArmonAir RespiClick by the U.S. Food and Drug Administration.
Keep Reading →
February 2 - News, Stock Analysis
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...
Keep Reading →
January 26 - Lists, News
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially...
Keep Reading →
January 17 - Lists, News
NeRRe Therapeutics, which is a GlaxoSmithKline PLC (ADR) (NYSE:GSK) spinout, has raised £23 million ($28 million) in a Series B financing round.
Keep Reading →
January 6 - News, Stock Analysis
It takes a lot of guts for an individual to stand up against huge corporate entities for the overall well-being of the society.
Keep Reading →
December 30 - Lists, News
Efforts by GlaxoSmithKline plc (ADR) (NYSE:GSK) in carrying out a large study on its new HIV drug are yielding positive results.
Keep Reading →
December 21 - News, Stock Analysis
The National Institute for Health and Care Excellence (NICE) has confirmed the approval of a new injectable asthma drug from GlaxoSmithKline PLC (ADR) (NYSE:GSK).
Keep Reading →
December 2 - News, Stock Analysis
GlaxoSmithKline plc (ADR) (NYSE:GSK) has moved to expand the target market for its blockbuster vaccine, Shingrix, with the filing of a regulatory application in Europe.
Keep Reading →
November 30 - News, Stock Analysis
Theravance Biopharma Inc (NASDAQ:TBPH) just put out an announcement relating to its closed triple asset, and the company is trading flat-to-down despite the seemingly positive...
Keep Reading →
November 22 - News, Stock Analysis
No stock is ever a sure thing, but that doesn’t mean you can’t get asymptotically close to one. Following the announcement by VBI Vaccines, Inc.
Keep Reading →
November 14 - News, Stock Analysis
The US Food and Drug Administration (FDA) has recently cleared the Propeller platform of Propeller Health for use with GlaxoSmithKline Plc (ADR) (NYSE:GSK)'s Ellipta dry powder...
Keep Reading →
November 8 - News, Stock Analysis
Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager...
Keep Reading →
November 8 - Hedge Fund Analysis, Hedge Funds, News
GlaxoSmithKline plc (ADR) (NYSE:GSK) (GSK) has recently entered into a collaborative agreement with Fimbrion Therapeutics, Inc.
Keep Reading →
October 26 - News, Stock Analysis
GlaxoSmithKline Plc (NYSE:GSK) is forging forward with its cold and flu tracker app even on coming under criticism from skeptics who continue to question the motive behind its...
Keep Reading →
October 19 - News, Stock Analysis
Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline PLC (ADR) (NYSE:GSK) have yielded fruit...
Keep Reading →
September 20 - News, Stock Analysis
Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing document detailing the process...
Keep Reading →
August 29 - News, Stock Analysis
Markets are struggling to find a direction on Monday amid the Institute for Supply Management data that showed that its index of national factory activity amounted to 52.6 in...
Keep Reading →
August 1 - Earnings Report, News, Tech
The U.S stock markets are trading up on Monday even as oil has tumbled, thanks to strong financial results and M&A news. Among the stocks on the move today are LendingClub Corp...
Keep Reading →
July 18 - Market Movers, News
The Brexit is looming and, no matter how cute a name we can come up with, the issue is as serious as can be.
Keep Reading →
June 13 - Hedge Fund Analysis, Hedge Funds
GlaxoSmithKline plc (ADR) (NYSE:GSK) has come up with a plan that will enable it to file for approval of its triple-combo drug for COPD patients sooner than earlier anticipated...
Keep Reading →
June 9 - News, Stock Analysis
A drug being developed jointly by Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline plc (ADR) (NYSE:GSK) met endpoints in a large Phase 3 study that enrolled 1,670 patients...
Keep Reading →
June 8 - News, Stock Analysis